Thursday, April 03, 2014 1:37:52 PM
Long term this company has great things outside of Trimesta so the degree of risk is minimized.
Seel made a point and maybe it was on the board but regardless of positive or negative results for Trimesta they will be discussed in order advance scientific discovery. I do agree that one cannot predict results will be positive and this is a very stringent trial design so that makes it tougher to say one way or the other. Just based on patient type and results in earlier study's with this patient type I feel good about what will be released. But that is just my opinion and I'm not a statician nor am I claiming to be an expert on looking at clinical studies.
At any rate long term I will be good due to the pipeline in development and that allows me more confidence to see the results laid out for Trimesta.
Dr V will be presenting top line data in one presentation and in another presentation she will discuss the MOA of Trimesta. There will be a great deal of info to look at...
GLTE
Seel made a point and maybe it was on the board but regardless of positive or negative results for Trimesta they will be discussed in order advance scientific discovery. I do agree that one cannot predict results will be positive and this is a very stringent trial design so that makes it tougher to say one way or the other. Just based on patient type and results in earlier study's with this patient type I feel good about what will be released. But that is just my opinion and I'm not a statician nor am I claiming to be an expert on looking at clinical studies.
At any rate long term I will be good due to the pipeline in development and that allows me more confidence to see the results laid out for Trimesta.
Dr V will be presenting top line data in one presentation and in another presentation she will discuss the MOA of Trimesta. There will be a great deal of info to look at...
GLTE
Recent TOVX News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 09:23:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/09/2026 08:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 12:10:12 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/16/2026 09:32:27 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 12:15:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:10:35 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/04/2026 09:35:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:10:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 01:07:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 02:11:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:55:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:54:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:53:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 09:51:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/06/2026 08:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2025 01:00:58 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/23/2025 10:04:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2025 10:21:47 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/03/2025 09:00:29 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/03/2025 05:15:04 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/12/2025 09:11:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 01:16:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 01:10:35 PM
